Epidemiology of chronic kidney disease among residents of Moscow


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Assessment of the prevalence of chronic kidney disease (ckd) in the population is critical for planning and preventing kidney disease for the medical community and government. objective. this study estimated the prevalence of ckd among the adult population of Moscow. material and methods. ckd stages i-5 were determined by the method of calculating glomerular filtration rate (GFR) using the ckd-epi equation. results. we found that patients with stage i-5 ckd accounted for 4% of the total population, of which 4.8% were patients with stages 4-5, but this prevalence is less than in most other countries. Conclusion. This study showed a high prevalence of ckd among the population of Moscow, although it was limited by the lack of accounting for changes in urinalysis. at the same time, the analysis of the prevalence of ckd by stages showed a high proportion of the early stages of ckd with significantly lower detection rates of late stages. the latter fact, most likely, suggests that the mass of patients with ckd do not survive to the late stages of this pathology.

Full Text

Restricted Access

About the authors

Marina Yu. Dudko

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

Email: dudkomarina@mail.ru
PhD in Medical Sciences, Nephrologis Moscow, Russia

Oleg N. Kotenko

City Clinical Hospital № 52 of the Moscow Healthcare Department; Peoples' Friendship University of Russia

PhD in Medical Sciences, Chief External Expert in Nephroloigy; Associate Professor at the Department of Hospital Therapy with a Course of Hematology Moscow, Russia

Evgeny V. Shutov

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department; Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: shutov_e_v@mail.ru
Doctor of Medical Sciences, Head of the Department of Nephrology № 12; Professor at the Department of Nephrology and Hemodialysis Moscow, Russia

Nadezhda V. Vasina

City Clinical Hospital № 52 of the Moscow Healthcare Department

Email: omo52@yandex.ru
Head of the Organizational and Methodological Department for Nephrology Moscow, Russia

References

  1. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., Van Lente F, Levey A.S. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-47. doi: 10.1001/jama.298.17.2038
  2. Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., Jafar T.H., Heerspink H.J., Mann J.F., Matsushita K., Wen C.P. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339-52. doi: 10.1016/S0140-6736(13)60595-4
  3. McCullough K., Sharma P., Ali T., Khan I., Smith W.C., MacLeod A., Black C. : Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol. Dial. Transplant. 2012;27:1812-21. doi: 10.1093/ndt/gfr547
  4. BrUck K, Stel V.S., Gambaro G., et al. CKD Prevalence Varies across the European General Population. J. Am. Soc. Nephrol. 2016;27(7):2135-47. doi: 10.1681/ASN.2015050542
  5. Tanner R.M., Gutiirrez O.M., Judd S., McClellan W., Bowling C.B., Bradbury B.D., Safford M.M., Cushman M., Warnock D., Muntner P. Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am. J. Kidney Dis. 2013;61:395-403.
  6. Zhang L., Wang F., Wang L., Wang W., Liu B., Liu J., Chen M., He Q., Liao Y., Yu X., Chen N., Zhang J.E., Hu Z., Liu F., Hong D., Ma L., Liu H., Zhou X., Chen J., Pan L., Chen W, Wang W, Li X., Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815-22.
  7. Fraser S.D., Roderick P.J., Aitken G., et al. Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. Kidney Int. Rep. 2019;4(9):1261-70.
  8. Nothlings U., Boeing H., Maskarinec, et al. Food intake of individuals with and without diabetes across different countries and ethnic groups. Eur. J. Clin. Nutr. 2011;65:635-41.
  9. Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y., Yang C.W. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-72.
  10. Jacobsen F.K., Christensen C.K., Mogensen C.E., Andreasen F., Heilskov N.S. Pronounced increase in serum creatinine concentration after eating cooked meat. BMJ. 1979;1:1049-50.
  11. Friedman A.N. High-protein diets:potential effects on the kidney in renal health and disease. Am. J. Kidney Dis. 2004;44:950-96.
  12. Chrysohoou C., Panagiotakos D.B., Pitsavos C., et al. Adherence to the Mediterranean diet is associated with renal function among healthy adults: the ATTICA study. J. Ren. Nutr. 2010;20:176-84.
  13. Boger C.A., Gorski M., Li M., Hoffmann M.M., et al. CKD Gen Consortium. Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet. 2011;7:e1002292.
  14. Kottgen A., Glazer N.L., Dehghan A., Hwang S.J., et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 2009;41:712-17.
  15. Kiryluk K., Li Y., Sanna-Cherchi S. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8:e1002765.
  16. Vart P., Gansevoort R.T., Joosten M.M., et al. Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis. Am. J. Prev. Med. 2015;48(5):580-92.
  17. Приказ Министерства здравоохранения Российской Федерации от 20 декабря 2012 г. №1268н «Об утверждении стандарта специализированной медицинской помощи при хронической болезни почек 5 стадии в преддиализном периоде, при госпитализации с целью подготовки к заместительной почечной терапии».
  18. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;3(1):1-136.
  19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002;39,2(Suppl. 1):1-266.
  20. Levey A.S., de Jong P.E., Coresh J., El Nahas M., Astor B.C., Matsushita K., et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2010;80:17-28.
  21. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F. 3rd, Feldman H.I., et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009;150:604-12.
  22. Stengel B., Tarver-Carr M.E., Powe N.R., et al.: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiol. 2003;14:479-87.
  23. Silverwood R.J., Pierce M., Hardy R., et al. : Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney Int. 2013;84:1262-70.
  24. Meyer K.B., Levey A.S. Controlling the epidemic of cardiovascular disease in chronic renal disease: Report from the National Kidney Foundation Task Force on cardiovascular disease. J. Amer. Soc. Nephrol. 1998;9(Suppl. 12):31-42.
  25. Munger M.A., Ateshkadi A., Cheung A.K., et al. Cardiopulmonary events during hemodialysis: Effects of dialysis membranes and dialysate buffers. Amer. J. Kidney Dis. 2000;36:130-39.
  26. Narula, A.S., Jha V., Bali H.K., et al. Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren. Fail. 2000;22:355- 68.
  27. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. U. S. Renal Data System, USRDS 1998 Annual Data Report.
  28. Noel D., Landais P. Epidemiology of chronic kidney disease. Rev. Prat. 2012;62(1):38-42.
  29. US Renal Data System Chapter 9. Healthcare Expenditures for Persons with ESRD. 2017.
  30. Kao T.-W., Chang Y.-Y., Chen P.-C. Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan. Perit. Dial. Int. 2013;33:671-78.
  31. Bureau of National Health Insurance National Health Insurance Annual Statistical Report. Taiwan; 2002.
  32. Nawata K., Kimura M. Evaluation of medical costs of kidney diseases and risk factors in Japan. Health. 2017;9:1734-49.
  33. Котенко О.Н. Хроническая болезнь почек: проблемы и решения. Московская медицина 2018;1(22). С. 21-4.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies